Disc Medicine, Inc.
IRON
$70.03
$1.502.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 104.99% | 97.83% | 78.65% | 68.57% | 51.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 91.56% | 81.29% | 63.03% | 52.06% | 41.80% |
| Operating Income | -91.56% | -81.29% | -63.03% | -52.06% | -41.80% |
| Income Before Tax | -107.98% | -94.33% | -74.94% | -59.46% | -44.10% |
| Income Tax Expenses | -37.53% | 1.69% | 112.80% | 294.02% | 479.01% |
| Earnings from Continuing Operations | -107.40% | -94.03% | -75.02% | -59.76% | -44.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -107.40% | -94.03% | -75.02% | -59.76% | -44.54% |
| EBIT | -91.56% | -81.29% | -63.03% | -52.06% | -41.80% |
| EBITDA | -91.52% | -81.29% | -63.10% | -52.20% | -41.80% |
| EPS Basic | -68.52% | -50.10% | -34.97% | -22.19% | -16.22% |
| Normalized Basic EPS | -68.40% | -49.72% | -32.82% | -19.92% | -16.16% |
| EPS Diluted | -68.52% | -50.10% | -34.97% | -22.19% | -16.22% |
| Normalized Diluted EPS | -68.40% | -49.72% | -32.82% | -19.92% | -16.16% |
| Average Basic Shares Outstanding | 23.06% | 27.88% | 27.36% | 29.28% | 25.08% |
| Average Diluted Shares Outstanding | 23.06% | 27.88% | 27.36% | 29.28% | 25.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |